Claris Ventures is a venture capital firm established in 2019 and based in Turin, Italy. The firm specializes in early-stage investments in high-potential biopharmaceutical companies that emerge from the Italian research and development ecosystem. By focusing on innovative biopharma ventures, Claris Ventures aims to support the growth of companies that are poised to make significant contributions to the healthcare sector.
IAMA Therapeutics is a biotechnology company focused on advancing neuroscience drug discovery to develop innovative treatments for children with brain disorders. The company aims to address neurological conditions, offering therapeutic solutions that target learning and memory difficulties associated with Down syndrome and the behavioral challenges linked to autism spectrum disorders. By prioritizing the needs of affected children and their families, IAMA Therapeutics strives to create impactful medicines that improve the quality of life for patients while providing essential support to their families.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.